DE602005001765D1 - Kapillarmoderator in einem osmotischen abgabesystem zur prävention von rückfluss in das wirkstoffreservoir - Google Patents

Kapillarmoderator in einem osmotischen abgabesystem zur prävention von rückfluss in das wirkstoffreservoir

Info

Publication number
DE602005001765D1
DE602005001765D1 DE602005001765T DE602005001765T DE602005001765D1 DE 602005001765 D1 DE602005001765 D1 DE 602005001765D1 DE 602005001765 T DE602005001765 T DE 602005001765T DE 602005001765 T DE602005001765 T DE 602005001765T DE 602005001765 D1 DE602005001765 D1 DE 602005001765D1
Authority
DE
Germany
Prior art keywords
active substance
distribution system
preventing backflow
osmotic
moderator
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005001765T
Other languages
English (en)
Inventor
Li-Wei Pan
Rodney M Panos
Eli Joseph Goldman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alza Corp
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of DE602005001765D1 publication Critical patent/DE602005001765D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A61M5/145—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
    • A61M2005/14513—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons with secondary fluid driving or regulating the infusion

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Materials For Medical Uses (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Catching Or Destruction (AREA)
  • Feeding, Discharge, Calcimining, Fusing, And Gas-Generation Devices (AREA)
DE602005001765T 2004-02-10 2005-02-09 Kapillarmoderator in einem osmotischen abgabesystem zur prävention von rückfluss in das wirkstoffreservoir Active DE602005001765D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US54342304P 2004-02-10 2004-02-10
US11/052,382 US20050175701A1 (en) 2004-02-10 2005-02-07 Capillary moderator for osmotic delivery system
PCT/US2005/004277 WO2005077334A1 (en) 2004-02-10 2005-02-09 Capillary moderator in an osmotic delivery system for preventing backflow into the active agent reservoir

Publications (1)

Publication Number Publication Date
DE602005001765D1 true DE602005001765D1 (de) 2007-09-06

Family

ID=34829897

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005001765T Active DE602005001765D1 (de) 2004-02-10 2005-02-09 Kapillarmoderator in einem osmotischen abgabesystem zur prävention von rückfluss in das wirkstoffreservoir

Country Status (11)

Country Link
US (1) US20050175701A1 (de)
EP (1) EP1718275B1 (de)
JP (1) JP2007521887A (de)
AT (1) ATE367799T1 (de)
AU (1) AU2005212365A1 (de)
CA (1) CA2555887A1 (de)
DE (1) DE602005001765D1 (de)
HK (1) HK1097197A1 (de)
NZ (1) NZ548716A (de)
TW (1) TW200539899A (de)
WO (1) WO2005077334A1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY125870A (en) * 1997-07-25 2006-08-30 Alza Corp Osmotic delivery system flow modulator apparatus and method
US7258869B1 (en) 1999-02-08 2007-08-21 Alza Corporation Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
US7919109B2 (en) * 1999-02-08 2011-04-05 Intarcia Therapeutics, Inc. Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
AU2003251535B2 (en) * 2002-06-17 2008-12-18 Intarcia Therapeutics, Inc. Osmotic delivery system with early zero order push power engine comprising an osmotic agent dispersed in the fluid vehicle
US7731947B2 (en) * 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
AR043809A1 (es) * 2003-03-31 2005-08-17 Alza Corp Bomba osmotica con medio para disipar la presion interna
BRPI0408921A (pt) * 2003-03-31 2006-03-28 Alza Corp sistema de distribuição osmótico e método para diminuir os tempos de inìcio para os sistemas de distribuição osmóticos
BRPI0416094A (pt) * 2003-10-31 2007-01-02 Alza Corp bomba osmótica com plugue de membrana de inicialização rápida, de auto-retenção
KR20060121890A (ko) * 2003-11-06 2006-11-29 알자 코포레이션 이식형 삼투 펌프와 함께 사용하기 위한 모듈식 흡수율감소기
US20050266087A1 (en) * 2004-05-25 2005-12-01 Gunjan Junnarkar Formulations having increased stability during transition from hydrophobic vehicle to hydrophilic medium
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
CA2596966A1 (en) * 2005-02-03 2006-08-10 Intarcia Therapeutics, Inc. Implantable osmotic device for continuous delivery of suspension formulations
US7959938B2 (en) 2005-03-15 2011-06-14 Intarcia Therapeutics, Inc. Polyoxaester suspending vehicles for use with implantable delivery systems
MX2008014870A (es) 2006-05-30 2009-02-12 Intarcia Therapeutics Inc Modulador de flujo para sistema de suministro osmotico con canal interno de dos piezas.
ES2422864T3 (es) * 2006-08-09 2013-09-16 Intarcia Therapeutics, Inc Sistemas de liberación osmótica y unidades de pistón
AU2008244523B2 (en) * 2007-04-23 2012-02-16 Intarcia Therapeutics, Inc. Suspension formulations of insulinotropic peptides and uses thereof
US8343140B2 (en) 2008-02-13 2013-01-01 Intarcia Therapeutics, Inc. Devices, formulations, and methods for delivery of multiple beneficial agents
CN104013569A (zh) * 2008-10-15 2014-09-03 精达制药公司 高浓缩药物颗粒、制剂、混悬剂及其应用
EP3735944A1 (de) 2009-09-28 2020-11-11 Intarcia Therapeutics, Inc. Schnelle initiierung und/oder beendigung der verabreichung substantiell stabiler arzneimittel
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
DK2869870T3 (en) 2012-07-06 2019-03-11 Sanofi Aventis Deutschland PHARMACEUTICAL MANAGEMENT DEVICE
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
EP4278996A3 (de) 2015-06-03 2024-01-24 i2o Therapeutics, Inc. Systeme zum einsetzen eines implantats
ES2916325T3 (es) 2015-11-05 2022-06-30 Massachusetts Gen Hospital Administración intratecal de secuencias de ácidos nucleicos codificantes de ABCD1 para el tratamiento de la adrenomieloneuropatía
AU2017268161B2 (en) 2016-05-16 2020-03-12 Intarcia Therapeutics, Inc. Glucagon-receptor selective polypeptides and methods of use thereof
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
EP3528836A1 (de) 2016-10-20 2019-08-28 Peptron, Inc. Verfahren zur abgabe eines neuroprotektiven polypeptids an das zentrale nervensystem
CA3049034A1 (en) 2017-01-03 2018-07-12 Intarcia Therapeutics, Inc. Methods comprising continuous administration of a glp-1 receptor agonist and co-adminstration of a drug
WO2018165462A1 (en) 2017-03-08 2018-09-13 Intarcia Therapeutics, Inc Apparatus and methods for administration of a nauseogenic compound from a drug delivery device
USD933219S1 (en) 2018-07-13 2021-10-12 Intarcia Therapeutics, Inc. Implant removal tool and assembly
CN110856987A (zh) * 2018-08-22 2020-03-03 东北林业大学 一种压力转换快速且便捷sls木塑复合材料后处理装置
CA3116023A1 (en) 2018-10-11 2020-04-16 Intarcia Therapeutics, Inc. Human amylin analog polypeptides and methods of use
CN113548937B (zh) * 2020-04-26 2023-09-05 浙江蓝天环保高科技股份有限公司 一种高纯度全氟-2,4-二甲基-3-庚烯的连续制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3760806A (en) * 1971-01-13 1973-09-25 Alza Corp Helical osmotic dispenser with non-planar membrane
US4455145A (en) * 1981-07-10 1984-06-19 Alza Corporation Dispensing device with internal drive
US4755180A (en) * 1986-06-16 1988-07-05 Alza Corporation Dosage form comprising solubility regulating member
ES2233768T3 (es) * 1996-02-02 2005-06-16 Alza Corporation Liberacion prolongada de un agente activo utilizando un sistema implantable.
ZA981610B (en) * 1997-03-24 1999-08-26 Alza Corp Self adjustable exit port.
ES2378675T3 (es) * 1997-12-30 2012-04-16 Intarcia Therapeutics, Inc Sistema de suministro de un agente beneficioso con una membrana obturadora
DK1328256T3 (da) * 1999-12-21 2006-02-20 Alza Corp Ventil til osmotiske indretninger
MXPA04002476A (es) * 2001-09-14 2004-05-31 Anthony A Boiarski Dispositivo de nanoporo microfabricado para la liberacion sostenida de agente terapeutico.
WO2004101017A2 (de) * 2003-05-16 2004-11-25 Blue Membranes Gmbh Biokompatibel beschichtete medizinische implantate

Also Published As

Publication number Publication date
TW200539899A (en) 2005-12-16
ATE367799T1 (de) 2007-08-15
WO2005077334A8 (en) 2006-07-06
AU2005212365A1 (en) 2005-08-25
CA2555887A1 (en) 2005-08-25
JP2007521887A (ja) 2007-08-09
NZ548716A (en) 2009-07-31
HK1097197A1 (en) 2007-06-22
EP1718275A1 (de) 2006-11-08
EP1718275B1 (de) 2007-07-25
WO2005077334A1 (en) 2005-08-25
US20050175701A1 (en) 2005-08-11

Similar Documents

Publication Publication Date Title
DE602005001765D1 (de) Kapillarmoderator in einem osmotischen abgabesystem zur prävention von rückfluss in das wirkstoffreservoir
IL258702B (en) Pump system for use in organ treatment systems
MX2010006840A (es) Aparato y métodos para suministrar agentes terapeuticos.
ATE521406T1 (de) Fluidadditivzufuhrsysteme
EP1816995A4 (de) Kartusche, vorrichtung und verfahren zum aufbewahren, mischen und abgeben eines pharmazeutikums
EA201000747A1 (ru) Система и способ трансдермальной доставки и способ получения системы трансдермальной доставки
ATE493161T1 (de) Medizinisches abgabesystem mit asymmetrischen kodiervorrichtungen
MX2007002189A (es) Sales de dicetopiperazina, sales de dicetomorfolina o sales de dicetodioxano para suministro de farmacos.
CL2003002277A1 (es) Composicion farmaceutica inyectable, de deposito de liberacion prolongada, que comprende un agente beneficioso disuelto o disperso en un gel constituido por un polimero bioerosionable y biocompatible; y un solvente.
GB2453069B (en) Devices,systems and methods for medicament delivery
IL181436A0 (en) Transdermal antiemesis delivery system, method and composition therefor
ATE425782T1 (de) Vorrichtung zur abgabe eines medikaments
UA85574C2 (uk) Ендопаразитоцидний засіб для місцевого застосування
MY155032A (en) High fluoride ion oral care composition and method for maintaining anticaries activity
GB2433809B (en) Communication device and related content output method and supply system,distribution server and method
ATE444801T1 (de) Dosierpumpenaggregat
HK1132692A1 (en) Breathable air safety system and method having an air storage sub-system
SE0402336L (sv) Pumpstation, och anordning avsedd att användas i sådan
UY28762A1 (es) Nuevos compuestos
FR2939321B1 (fr) Dispositif de conditionnement et d'administration de principes actifs en solution hydro-alcoolique.
ITMI20030972A1 (it) Indazolo dotato di attivita' analgesica, metodo per prepararlo e composizione farmaceutica che lo comprende.
Goodman Dennis W. Cole
UA96940C2 (ru) Композиция, которая содержит агент для стабилизации активных ингредиентов в питьевой воде и шипучую смесь, способ приготовления такой композиции и ее использование
FR2877923B1 (fr) Dispositif de distribution lente d'un liquide, notamment un parfum
FR2903300B1 (fr) Procede de distribution d'un ou plusieurs medicaments et dispositif mettant en oeuvre ledit procede

Legal Events

Date Code Title Description
8332 No legal effect for de